Patents by Inventor Armin Blesch

Armin Blesch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7157435
    Abstract: The invention provides a clinically useful protocol for delivery of recombinant nervous system growth factors into the aging mammalian brain. The invention is particularly useful in tempering and reversing the loss of neurological function in the aging mammalian brain, by (a) correlating loss of cortical fiber density to impairment of neurological function in the normal, aging brain; and (b) providing minimally invasive means by which such losses may be reversed. To these ends, a method is provided by which a growth factor-encoding transgene is delivered to, and expressed in, preselected sites within the brain, to stimulate growth of neurons at, and at a distance from, each delivery site.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: January 2, 2007
    Assignee: The Regents of the University of California
    Inventors: Mark H. Tuszynski, Armin Blesch
  • Publication number: 20030040082
    Abstract: Mutant “pro-neurotrophins” whose corresponding growth factor is secreted more efficiently from host cells than wild-type growth factor. Such improved activity is obtained through substitution of a residue in the precursor protein (“prepro”) region of a pro-form of a growth factor. Pro-neurotrophins contain at least one conserved asparagine-based N-glycosylation site present upstream of the cleavage site for separation of the corresponding neurotrophin. The invention substitutes the asparagine with a basic residue, such as serine. At the higher levels of extracellular growth factor achieved by the invention, the bioavailability, and therefore the therapeutic potential of the corresponding mature protein is enhanced.
    Type: Application
    Filed: February 16, 2001
    Publication date: February 27, 2003
    Inventors: Mark Tuszynski, Armin Blesch
  • Publication number: 20010043920
    Abstract: The invention provides a clinically useful protocol for delivery of recombinant nervous system growth factors into the aging mammalian brain. The invention is particularly useful in tempering and reversing the loss of neurological function in the aging mammalian brain, by (a) correlating loss of cortical fiber density to impairment of neurological function in the normal, aging brain; and (b) providing minimally invasive means by which such losses may be reversed. To these ends, a method is provided by which a growth factor-encoding transgene is delivered to, and expressed in, preselected sites within the brain, to stimulate growth of neurons at, and at a distance from, each delivery site.
    Type: Application
    Filed: December 5, 2000
    Publication date: November 22, 2001
    Inventors: Mark H. Tuszynski, Armin Blesch